Germany: Federal Institute for Drugs and Medical Devices [clinicaltrials_resource:3bb665147521d7b41fff74363a900fcb]
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer [clinicaltrials:NCT00032162]clinicaltrials:NCT00052468clinicaltrials:NCT00098137clinicaltrials:NCT00102869clinicaltrials:NCT00111345clinicaltrials:NCT00117702Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure [clinicaltrials:NCT00124969]Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide [clinicaltrials:NCT00125606]Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction (AMI)(REVIVAL-2) [clinicaltrials:NCT00126100]Intra-Individual Comparison of Sirolimus and Paclitaxel Coated Stent (FRE-RACE Study) [clinicaltrials:NCT00130546]Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2) [clinicaltrials:NCT00133003]Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3) [clinicaltrials:NCT00133250]clinicaltrials:NCT0013631875 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2) [clinicaltrials:NCT00140465]Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome [clinicaltrials:NCT00146471]Energy Homeostasis Under Treatment With Atypical Antipsychotics [clinicaltrials:NCT00148564]Memantine for the Prevention of Negative Symptomatology [clinicaltrials:NCT00148590]Memantine for the Treatment of Negative Symptomatology [clinicaltrials:NCT00148616]clinicaltrials:NCT00150839clinicaltrials:NCT00150878clinicaltrials:NCT00153972Helicobacter – Lymphoma – Radiation Part I: Eradication, Part II: Radiation [clinicaltrials:NCT00154440]One Year Drug Treatment in First-Episode Schizophrenia [clinicaltrials:NCT00159081]Integrative Therapy in Alcoholism [clinicaltrials:NCT00159107]Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia [clinicaltrials:NCT00159120]Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia [clinicaltrials:NCT00159133]clinicaltrials:NCT00160966clinicaltrials:NCT00167583Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study) [clinicaltrials:NCT00168909]Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions [clinicaltrials:NCT00171964]Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis [clinicaltrials:NCT00172003]clinicaltrials:NCT00176124Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease [clinicaltrials:NCT00180037]clinicaltrials:NCT00180310clinicaltrials:NCT00191477FFS - Far Field Sensing Test Study in Cardiac Dual Chamber Pacemakers [clinicaltrials:NCT00196144]Line Versus Spot Ablation in Persistent Atrial Fibrillation [clinicaltrials:NCT00196157]Randomized Study of Radiofrequency- vs. Cryo-Ablation for Typical Isthmus-Dependent Atrial Flutter [clinicaltrials:NCT00196170]Trigger- vs. Substrate-Ablation for Paroxysmal Atrial Fibrillation [clinicaltrials:NCT00196183]Cardioversion vs. Catheter Ablation for Persistent Atrial Fibrillation [clinicaltrials:NCT00196209]
oversight [clinicaltrials_vocabulary:oversight]
Germany: Federal Institute for Drugs and Medical Devices [clinicaltrials_resource:3bb665147521d7b41fff74363a900fcb]
Bio2RDF identifier
3bb665147521d7b41fff74363a900fcb
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3bb665147521d7b41fff74363a900fcb
has dmc [clinicaltrials_vocabulary:has-dmc]
identifier
clinicaltrials_resource:3bb665147521d7b41fff74363a900fcb
title
Germany: Federal Institute for Drugs and Medical Devices
@en
type
label
Germany: Federal Institute for ...... 665147521d7b41fff74363a900fcb]
@en